Can Wellbutrin (bupropion) cause tinnitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin and Tinnitus

Yes, Wellbutrin (bupropion) can cause tinnitus as a documented adverse effect, occurring in 2-6% of patients in clinical trials, with the incidence increasing at higher doses. 1

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for bupropion explicitly lists tinnitus as a known adverse reaction:

  • In major depressive disorder trials: Tinnitus occurred in 2% of placebo patients, 6% of patients taking 300 mg/day, and 6% of patients taking 400 mg/day of bupropion sustained-release 1
  • In seasonal affective disorder trials: Tinnitus occurred in <1% of placebo patients versus 3% of patients taking bupropion extended-release 1
  • Postmarketing reports: Tinnitus has been reported as an adverse reaction during post-approval use of bupropion 1

Clinical Significance and Dose Relationship

The risk of tinnitus appears dose-related, with 300 mg/day and 400 mg/day showing 6% incidence compared to 2% with placebo. 1 This represents a 3-fold increased risk compared to placebo, making it a clinically meaningful adverse effect that should be discussed with patients before initiating treatment.

Mechanism and Context

While the exact mechanism is not fully elucidated, antidepressants including bupropion can affect auditory processing through complex interactions between serotonergic, glutamatergic, and GABAergic neurotransmitter systems in the cochlea and central auditory pathways 2, 3. Bupropion's dopaminergic and noradrenergic effects may similarly influence auditory filtering mechanisms.

Clinical Management Recommendations

If a patient develops tinnitus after starting bupropion:

  • Perform otoscopy to exclude cerumen impaction, middle ear infection, or other treatable otologic causes 4, 5
  • Determine if the tinnitus is unilateral or bilateral, pulsatile or non-pulsatile 4, 5
  • For bilateral, non-pulsatile tinnitus without neurologic deficits: Imaging is not indicated 4
  • For unilateral tinnitus: Consider MRI of internal auditory canals to exclude vestibular schwannoma 4
  • Consider dose reduction or discontinuation of bupropion if tinnitus is bothersome and no other cause is identified 1
  • Monitor for resolution after discontinuation, as drug-induced tinnitus typically resolves when the offending agent is stopped 3

Important Caveats

Do not automatically attribute tinnitus to bupropion without excluding other causes, particularly in patients with:

  • Asymmetric hearing loss (requires audiometry and possible MRI) 4, 5
  • Pulsatile tinnitus (requires CT or CTA to evaluate vascular abnormalities) 4
  • Concomitant use of other ototoxic medications (salicylates, aminoglycosides) 4, 3
  • Recent medication changes, including benzodiazepine withdrawal 6

The presence of tinnitus does not automatically require stopping bupropion if the symptom is mild and the medication is providing significant benefit for depression or ADHD. However, patients should be counseled about this potential side effect before starting treatment 1.

References

Research

Antidepressants for treatment of tinnitus.

Progress in brain research, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tinnitus Treatment with Otalgia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clonazepam Withdrawal and Tinnitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.